All Q2 FY27 results →
CS

Clean Science & Technology Ltd

Q2 FY27Chemicals & Petrochemicals

Clean Science & Technology Q2 Results 2026 (FY27) investor presentation: Revenue & Margins

Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.

Price₹716
Market cap₹7.6K Cr
P/E32.6
Updated31 Oct 2026
Read5 min read

Clean Science & Technology Ltd Q2 FY27 key numbers

Revenue
Q2 FY2027 consolidated sales of products: INR 295 crore, up 23% YoY (Q2 FY2026 sales: INR 240 crore).

As stated in Clean Science & Technology Ltd's Q2 FY27 investor presentation · published 31 Oct 2026. Reported figures, not investment advice.

Based on Clean Science & Technology Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

The short version

Q2 FY2027 consolidated sales of products: INR 295 crore, up 23% YoY (Q2 FY2026 sales: INR 240 crore) - Q2 FY2027 standalone sales of products: INR 226 crore, up 10% YoY (Q2 FY2026 sales: INR 206 crore) - Q2 FY2027 consolidated total revenue: INR 299 crore, up 22% YoY (Q2 FY2026: INR 245 crore) - Q2 FY2027 standalone total revenue: INR 233 crore, up 10% YoY (Q2 FY2026: INR 211 crore) - H1 FY2027 consolidated sales of products: INR 559 crore, up 17% YoY (H1 FY2026: INR 480 crore) - H1 FY2027 standalone sales of products: INR 430 crore, up 2% YoY (H1 FY2026: INR 423 crore) - H1 FY2027 consolidated total revenue: INR 568 crore, up 16% YoY (H1 FY2026: INR 488 crore) - H1 FY2027 standalone total revenue: INR 440 crore, up 2% YoY (H1 FY2026: INR 431 crore) - Outlook: HALS segment grew 2x in H1 FY27; commercial launch of advanced HALS expected in H2 FY27; Performance Chemical 2 expected to commercialize in H2 FY27. Q2 FY2027 Consolidated EBITDA: INR 92 crore, up 5% YoY - Q2 FY2027 Consolidated EBITDA margin: 31.2% (down from 36.4% YoY) - Q2 FY2027 Consolidated Profit after Tax (PAT): INR 56 crore, flat YoY

From Clean Science & Technology Ltd's Q2 FY27 earnings-call transcript · updated 31 Oct 2026.

Revenue & Sales Performance

  • Q2 FY2027 consolidated sales of products: INR 295 crore, up 23% YoY (Q2 FY2026 sales: INR 240 crore)
  • Q2 FY2027 standalone sales of products: INR 226 crore, up 10% YoY (Q2 FY2026 sales: INR 206 crore)
  • Q2 FY2027 consolidated total revenue: INR 299 crore, up 22% YoY (Q2 FY2026: INR 245 crore)
  • Q2 FY2027 standalone total revenue: INR 233 crore, up 10% YoY (Q2 FY2026: INR 211 crore)
  • H1 FY2027 consolidated sales of products: INR 559 crore, up 17% YoY (H1 FY2026: INR 480 crore)
  • H1 FY2027 standalone sales of products: INR 430 crore, up 2% YoY (H1 FY2026: INR 423 crore)
  • H1 FY2027 consolidated total revenue: INR 568 crore, up 16% YoY (H1 FY2026: INR 488 crore)
  • H1 FY2027 standalone total revenue: INR 440 crore, up 2% YoY (H1 FY2026: INR 431 crore)

2 more points from Clean Science & Technology Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Clean Science & Technology Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Significant greenfield CAPEX planned for commercializing a new series of products (Page 22).
  • Advanced HALS product trials completed at Clean Fino Chem Ltd. (CFCL), with commercial launch expected in H2 FY2026-27 (Page 5).
  • CFCL wholly owned subsidiary; incurred ~INR 150 crore capex during H1 FY2027 for investment in CFCL (Page 5).
  • Largest facility for HALS commercialized at CFCL in March 2024; located in Kurkumbh Industrial Area, Maharashtra; 34 acres site, benefits from tax incentives (Page 20).
  • Performance Chemical 2 expected to be commercialized in H2 FY2027 (Page 5).

2 more points from Clean Science & Technology Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Shiv Texchem
Rev 1Mar 2
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Clean Science & Technology Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Clean Science & Technology Ltd said on order book & pipeline — free account, 30 seconds.

Clean Science & Technology Ltd — Quarterly revenue & net profit

Revenue Net profit
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27

Q2 FY27 figures are not in this chart yet. Latest shown: Jun 2026 (Q1 FY27). The Q2 FY27 numbers from the filing are in the analysis on this page.

Reported quarterly figures (₹ Cr). Latest (Q1 FY27): revenue ₹268 Cr, net profit ₹73 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Aarti Industries Ltd (Q2 FY27)

    Revenue from Operations (Net) for the quarter ended 30th Sep 2026 (Consolidated): ₹3,668 Cr (Page 3) . Key results statement takeaways from Aarti Industries Ltd

  • Chembond Material Technologies Ltd (Q2 FY27)

    61% increase) . Key results statement takeaways from Chembond Material Technologies Ltd's Q2 FY27 results statement — and how it ranks against sector peers.

  • DMCC Speciality Chemicals Ltd (Q2 FY27)

    12,603.12 lakhs for the quarter ended 30th September 2025, representing a year-on-year increase of approximately 116.5%. Key results statement takeaways from DM

  • Vinati Organics Ltd (Q2 FY27)

    680.21 crores, up from Rs. Key results statement takeaways from Vinati Organics Ltd's Q2 FY27 results statement — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Clean Science & Technology Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Clean Science & Technology Ltd Q2 FY27 results?

Q2 FY2027 consolidated sales of products: INR 295 crore, up 23% YoY (Q2 FY2026 sales: INR 240 crore) - Q2 FY2027 standalone sales of products: INR 226 crore, up 10% YoY (Q2 FY2026 sales: INR 206 crore) - Q2 FY2027 consolidated total revenue: INR 299 crore, up 22% YoY (Q2 FY2026: INR 245 crore) - Q2 FY2027 standalone total revenue: INR 233 crore, up 10% YoY (Q2 FY2026: INR 211 crore) - H1 FY2027 consolidated sales of products: INR 559 crore, up 17% YoY (H1 FY2026: INR 480 crore) - H1 FY2027 standalone sales of products: INR 430 crore, up 2% YoY (H1 FY2026: INR 423 crore) - H1 FY2027 consolidated total revenue: INR 568 crore, up 16% YoY (H1 FY2026: INR 488 crore) - H1 FY2027 standalone total revenue: INR 440 crore, up 2% YoY (H1 FY2026: INR 431 crore) - Outlook: HALS segment grew 2x in H1 FY27; commercial launch of advanced HALS expected in H2 FY27; Performance Chemical 2 expected to commercialize in H2 FY27. Q2 FY2027 Consolidated EBITDA: INR 92 crore, up 5% YoY - Q2 FY2027 Consolidated EBITDA margin: 31.2% (down from 36.4% YoY) - Q2 FY2027 Consolidated Profit after Tax (PAT): INR 56 crore, flat YoY

What is Clean Science & Technology Ltd share price analysis?

Clean Science & Technology Ltd currently shows a neutral. The stock trades at a P/E of 32.6 with a market cap of ₹7,604 Cr. Investors should review the full earnings analysis for detailed insights.

Is Clean Science & Technology Ltd planning capital expenditure?

Significant greenfield CAPEX planned for commercializing a new series of products (Page 22). - Advanced HALS product trials completed at Clean Fino Chem Ltd.

Keep Clean Science & Technology Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.